Patent ID: 11866502
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 36:
37. The anti-FGFR2 antibody or antigen-binding fragment thereof of claim 30, comprising: an HCDR1 having the amino acid sequence of SEQ ID NO: 24; an HCDR2 having the amino acid sequence of SEQ ID NO: 6; an HCDR3 having the amino acid sequence of SEQ ID NO: 26; an LCDR1 having the amino acid sequence of SEQ ID NO: 30; an LCDR2 having the amino acid sequence of SEQ ID NO: 32; and an LCDR3 having the amino acid sequence of SEQ ID NO: 34.